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Abstract
Several studies have investigated the potential benefits of marine n-3 PUFA in CVD, generally suggesting a lower risk of CHD. However,
recent trials have questioned these results. This study investigated the association of fish consumption with dietary intake of marine n-3 PUFA
with incident myocardial infarction (MI). In a Danish cohort study, 57 053 subjects between 50 and 64 years of age were enrolled from 1993 to
1997. From national registries, we identified all cases of incident MI. Dietary fish consumption was assessed using a semi-quantitative food
questionnaire, including twenty-six questions regarding fish intake. In addition, we calculated the intake of total and individual marine
n-3 PUFA. During a median follow-up of 17·0 years, we identified 3089 cases of incident MI. For both men and women, a high intake of fatty
fish was inversely related to incident MI. Thus, when comparing the highest and the lowest quintile of fatty fish intake, we found a 12% lower
relative risk of MI in men (hazard ratio (HR) 0·88; 95% CI 0·77, 1·00) and a 22% lower relative risk in women (HR 0·78; 95% CI 0·63, 0·96) after
adjustments. For women, similar associations were observed for individual and total marine n-3 PUFA. In contrast, intake of lean fish was not
associated with MI. In conclusion, incident MI was inversely related to a high intake of fatty fish, but not lean fish. However, test for trends
across quintiles was not statistically significant. In general, this study supports the view that consumption of fatty fish may protect against MI.
Key words: Myocardial infarction: Cohort studies: Marine n-3 PUFA: Fish consumption
The potential benefit of marine n-3 PUFA on CHD has been
extensively examined in both observational studies and clinical
trials, with the majority of studies favouring a beneficial effect of
n-3 PUFA(1–4).
Thus, several prospective cohort studies have reported an
inverse relationship between fish consumption and CHD(1,5–14).
However, other studies have not supported these findings(15,16).
Most epidemiological studies have evaluated the dietary intake
of fish using questionnaires, but relatively few of these studies
have differentiated between different types of fish and their
content of marine n-3 PUFA. In this study, we evaluated
fish intake using detailed and validated FFQ, allowing us to
differentiate between consumption of fatty and lean fish, and
additionally to calculate the intake of total and individual
marine n-3 PUFA.
Large secondary prevention trials have been performed
evaluating dietary interventions with fish servings or supple-
mentation with fish oil capsules. Although earlier trials such
as the diet and reinfarction trial(17), Gruppo Italiano per lo
Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)
Prevenzione(18) and Japan EPA Lipid Intervention Study trials(19)
have demonstrated a reduction in CHD events following
consumption of marine n-3 PUFA, more recent trials have not
supported these findings(20–22). Controversy therefore still
remains regarding the potential benefits from fish consumption
and n-3 PUFA supplements in the prevention of CHD, and
guidelines are currently under review.
In this large Danish cohort study, including 3089 validated
cases of incident myocardial infarction (MI), we investigated the
association of fish consumption and dietary intake of marine
n-3 PUFA with incident MI. The present study is one of the
largest cohort studies on fish consumption and MI, and notably
the study includes a relatively high number of female cases.
Methods
Study population and design
The Danish Diet, Cancer and Health study is a prospective
cohort study, which has been described in detail previously(23).
Abbreviations: DPA, docosapentaenoic acid; ICD; International Classification of Disease; MI; myocardial infarction.
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In brief, 160 725 persons aged 50–64 years were invited
between December 1993 and May 1997. Inclusion criteria were
as follows: born in Denmark, living in the urban areas of
Copenhagen and Aarhus and not registered with a cancer
diagnosis in the Danish Cancer Registry at the time of invitation.
A total of 57 053 persons accepted the invitation and were
enrolled into the study. Participants registered with a previous
MI or cardiac arrest were excluded. If a cancer diagnosis
was reported, which was not already recorded in the Cancer
Registry at the time of invitation, participants were excluded in
line with the intention-to-include criteria. At baseline, each
participant filled in a detailed questionnaire on diet, lifestyle,
socio-economic status and medical history. Data from dietary
questionnaires were analysed in a traditional cohort design
including the entire cohort. Participants were followed-up until
July 2013. The present study was conducted according to the
Helsinki Declaration and approved by the regional Ethics
Committees.
Dietary assessment
At baseline, participants filled in a detailed 192-point,
semi-quantitative FFQ, including twenty-six specific questions
regarding the intake of fish and food products containing fish.
The questionnaire has been validated and described in detail
previously(24). In short, participants were asked to estimate their
daily intake of foods in natural units such as pieces of fruits,
slices of bread and glasses of different drinks. For mixed dishes
and meals, sex-specific portion sizes were calculated using data
from a calibration study. By multiplying the frequencies of
intake by the portion size, the individual average intake in g/d
of all foods and nutrients was calculated. Different species of
fish were categorised as either lean or fatty depending on their
content of n-3 PUFA, below or above 1 g/100 g, respectively.
Fatty fish mainly comprised herring, salmon, trout and
mackerel, whereas lean fish comprised mainly plaice, flounder
and cod(7).
The dietary intakes of specific nutrients including total and
individual marine n-3 PUFA – EPA, docosapentaenoic acid
(DPA) and DHA – were calculated using FoodCalc software
(www.ibt.ku.dk/jesper/foodcalc) based on Danish Food
Composition Tables.
Outcome assessment
We identified all participants in the cohort who were registered
with an incident diagnosis of MI in the Danish National Patient
Registry and/or the Danish Causes of Death Registry, according
to the International Classification of Disease (ICD) 8 (410.00–
410.99) or ICD-10 (I21.0–I21.9) coding, during the study period.
Furthermore, all cases of cardiac arrest (ICD-8: 427.27 or
ICD-10: I46.0–I46.9) were included if the arrest was considered
to be of cardiac origin after validation in each individual case.
The Danish National Patient Registry(25) contains information on
diagnoses and interventional procedures in relation to all
hospital ward admissions since 1977, whereas all visits to
outpatient clinics and emergency rooms have been registered
since 1995. The Danish Causes of Death Registry contains
diagnoses for all deaths since 1943. Patients were registered in
both registries in accordance with ICD-8 until 1 January 1995
and subsequently according to ICD-10. An earlier study from
our Department validated the MI diagnosis from baseline
through 2003 by complete review of all medical records, and
found a positive predictive value >92% when the diagnoses
were obtained from a hospital ward(26). All validated cases of MI
from the validation study were readily accepted as cases for the
present study. From January 2004 through July 2013, all
participants with an incident MI diagnosed from a ward were
accepted as cases without further validation. All other diagnoses
of incident MI and cardiac arrest were validated by reviewing a
complete list of diagnoses and interventional procedures
recorded in the Danish National Patient Registry for each
potential case. Cases of incident MI were categorised as fatal or
non-fatal depending on their vital status 28 d after the event.
Vital status was obtained using the Civil Registration System.
Statistics
Exposure variables were categorised into quintiles based on the
cohort distribution. A test for trend across quintiles was carried out.
Furthermore, we also evaluated the exposure variables as con-
tinuous variables using restricted cubic splines with three knots.
Measures of association were assessed using Cox propor-
tional hazards multivariate regression models with age as the
time axis and delayed entry. Analyses were conducted
separately for men and women. Participants were treated as at
risk from baseline until either MI, death, emigration or end of
follow-up occurred.
To address potential confounding, we adjusted for traditional
risk factors of MI (model A2), including smoking habits (never,
former or current (<15, 15–25, >25 g/d) smoker), BMI (kg/m2),
waist circumference (cm), physical activity (h/week), alcohol
intake (g/d), educational level (basic school, higher education:
1–3 or >3 years) and, for women, menopausal status (pre or
postmenopausal). Second, we adjusted for either medical
history (model B) or additional dietary covariates (model C) in
separate models. Regarding medical history, we adjusted for
history of diabetes mellitus (yes/no), hypertension (yes/no) or
hypercholesterolaemia (yes/no), including participants on
antihypertensive medications or lipid-lowering drug treatment,
respectively. Adjustment for additional dietary variables
depended on the exposure variable (details specified in the
relevant tables). All continuous variables were included in the
models as restricted cubic splines with five knots. Potential
confounders were selected a priori based on current knowledge
of risk factors for MI.
The proportional hazards assumption was checked by visual
inspection of log–log plots and by evaluation of scaled
Schoenfeld residuals, with no significant violations. Estimates
with P values (two-tailed) <0·05 were considered statistically
significant. STATA, version 13.1 (StataCorp. LP) was used for
statistical analysis.
Results
The Diet, Cancer and Health cohort included a total of 57 053
participants. From these, an initial 1506 were excluded when
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baseline questionnaires were missing (n 42) or when
participants were identified with a cancer diagnosis in the
Danish National Patient Registry before baseline (n 564). We
also excluded participants with previous MI or cardiac arrest
before inclusion (n 900). In our study population, we identified
3089 cases of incident MI during a median follow-up time of
17·0 years. After case verification, we excluded subjects for
whom information on one or more covariates used in the
adjusted analyses was missing (n 643). Thus, 3028 cases were
included in the final analyses (Fig. 1).
Baseline risk factors for CHD were generally more prevalent
in cohort members who experienced a MI during follow-up
(‘cases’) than in the cohort as a whole (Table 1). Accordingly,
we observed a larger proportion of men, higher age, BMI and
waist circumference, and a larger proportion of smokers
among cases. In contrast, cases had lower weekly physical
activity and lower educational level compared with the cohort.
With regard to medical history, more cases suffered from
hypertension, hypercholesterolaemia and diabetes mellitus.
Consumption of fruits and vegetables was lower among cases,
whereas we did not find any marked differences between cases
and the cohort with regard to fish consumption and use of fish
oil supplements. Baseline characteristics were also evaluated by
the intake of fatty and lean fish for men and women separately,
in order to describe potential confounders. Data are included
in the online Supplementary Material (online Supplementary
Table S1·2).
Fish consumption and incident myocardial infarction
The median intake of fatty fish was 15·1 and 12·2 g/d for
men and women, respectively, whereas the median intake
of lean fish was 24·4 and 21·0 g/d for men and women,
respectively, with minor variations between cases and cohort
(Table 1).
In Table 2, we present hazard ratios (HR) for the association
between fish consumption and incident MI distributed by
quintiles. For men, fatty fish intake was inversely associated
with MI in the four higher quintiles compared with the lowest.
The association was attenuated by adjustment for traditional
risk factors for MI, but the trend remained for the highest
quintile compared with the lowest when adjusting for tradi-
tional risk factors and medical history (HR 0·88; 95% CI 0·77,
1·00). For women, we found an inverse association between the
highest quintile of fatty fish consumption and MI, which
remained statistically significant after adjustment for traditional
risk factors and medical history (HR 0·78; 95% CI 0·63, 0·96).
Adjustment for dietary variables did not affect the measures of
association substantially; however, results for model C were not
statistically significant. The test for trends across quintiles was
not statistically significant in the adjusted models, and a linear
dose–response relationship could not be demonstrated. No
consistent associations were seen between consumption of lean
fish and MI, for neither men nor women.
In addition, fish intakes were evaluated as continuous vari-
ables, modulated as restricted cubic splines with three knots,
suggesting an inverse trend between intake of fatty fish and MI
for both men and women, whereas lean fish was not associated
with MI (Fig. 2).
Dietary intake of marine n-3 PUFA and incident
myocardial infarction
We also examined the intakes of individual and total marine n-3
PUFA (EPA, DPA and DHA). The median intake of total marine
n-3 PUFA was 0·7 and 0·6 g/d for men and women, respec-
tively. As expected, intake of fatty fish was highly correlated
with the calculated intake of marine n-3 PUFA (r 0·93,
P< 0·001). For men, we observed a trend towards a negative
association between EPA, DHA and total marine n-3 PUFA
when comparing the highest and lowest quintiles; however, the
associations were modest and not statistically significant for
any of the models (Table 3). Results were generally more
consistent, towards an inverse association, between marine
n-3 PUFA and incident MI for women. Accordingly, intake of
total and individual marine n-3 PUFA was inversely associated
with MI. However, only model B, adjusting for traditional risk
factors and medical history, remained statistically significant
when comparing the fifth quintile with the first (HR 0·81;
95% CI 0·66, 0·99). As with intake of fatty fish, the test for trends
was not statistically significant across quintiles in the adjusted
analyses.
The associations between total marine n-3 PUFA and MI,
modulated by restricted cubic splines, are presented in Fig. 2.
For women, we found a trend towards an inverse association
with MI, whereas for men the association was less strong.
Invited participants
n  160 725
The Diet, Cancer and Health cohort
n 57 053
Initial exclusions (n 1 506)
Missing questionnaire (n 42)
Cancer before entry (n 564)
MI or cardiac arrest before entry (n 900)
Study cohort
n 55 547
Study cohort
n 54 904
Cases
n 3089
Cases
n 3028
Excluded if missing ≥ 1 covariate
(n 643)
Cases (n 61)
Not cases (n 582)
Fig. 1. Flow chart of cohort selection process. MI, myocardial infarction.
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Table 1. Baseline characteristics of the cohort and cases with myocardial infarction*
(Medians and 10th and 90th percentiles (continuous variables) and numbers and percentages (categorical variables))
Men Women
Cohort (n 25913) Cases (n 2136) Cohort (n 28 991) Cases (n 892)
Variables Medians
10th; 90th
percentile Medians
10th; 90th
percentile Medians
10th; 90th
percentile Medians
10th; 90th
percentile
Age (years) 55·9 51·2; 63·3 57·7 51·7; 63·9 56·2 51·2; 63·2 59·3 52·4; 64·2
Physical activity (h/week) 2·0 0·0; 8·0 2·0 0·0; 8·0 2·5 0·0; 8·0 2·0 0·0; 7·0
BMI (kg/m2) 26·1 22·5; 31·1 26·9 23·2; 32·2 24·8 20·8; 31·2 25·9 20·9; 33·3
Waist circumference (cm) 95·0 84·0; 108·5 97·0 86·0; 112·0 80·0 69·0; 97·0 84·0 70·0; 102·0
Smoking
Never smoker
n 6772 389 12 719 242
% 26·1 18·2 43·9 27·1
Former smoker
n 8892 631 6797 173
% 34·3 29·5 23·5 19·4
<15 g/d
n 2744 265 4421 198
% 10·6 12·4 15·3 22·2
15–25 g/d
n 4522 509 4305 233
% 17·5 23·8 14·9 26·1
>25 g/d
n 2983 342 748 46
% 11·5 16·0 2·6 5·2
Educational level
Basic school
n 8867 923 9043 392
% 34·2 43·2 31·2 44·0
Higher education, 1–3 years
n 10814 796 14 556 413
% 41·7 37·3 50·2 46·3
Higher education, >3 years
n 6232 417 5392 87
% 24·1 19·5 18·6 9·8
Menopausal status
Postmenopausal
n – – 16 975 617
% – – 58·6 69·2
Premenopausal
n – – 9022 158
% – – 31·1 17·7
Medical history
Hypertension
n 3762 472 4984 277
% 14·5 22·1 17·2 31·1
Hypercholesterolaemia
n 2005 253 1762 13·1
% 7·7 11·8 6·1 117
Diabetes mellitus
n 677 115 435 39
% 2·6 5·4 1·5 4·4
Dietary variables (g/d)
Fruits (excluding juice) 117·7 27·0; 324·7 111·0 25·1; 313·2 172·4 49·1; 417·4 160·6 37·5; 399·2
Vegetables (including juice, excluding
potatoes)
151·8 62·7; 291·4 138·8 56·7; 277·5 171·9 69·8; 329·4 149·2 54·5; 318·3
Alcohol 19·4 3·6; 62·6 18·2 2·5; 62·7 9·3 1·0; 34·5 6·5 0·5; 31·9
Total energy intake (MJ/d) 9·9 7·1; 13·6 9·8 7·1; 13·4 8·0 5·7; 11·2 7·9 5·5; 11·1
Dietary fish intake
Fatty fish 15·1 4·4; 37·8 14·9 4·1; 37·2 12·2 3·6; 31·8 11·6 2·6; 31·0
Lean fish 24·4 10·1; 50·0 24·2 10·4; 51·2 21·0 9·2; 42·6 20·6 8·5; 43·3
Total fish 41·7 17·7; 81·5 41·1 17·3; 82·3 35·2 15·1; 69·8 34·4 12·8; 67·9
EPA (mg/d) 177·3 68·7; 379·1 176·5 65·7; 376·6 147·5 56·1; 321·7 145·2 48·3; 317·7
DPA (mg/d) 82·0 47·3; 134·5 82·7 46·5; 136·5 61·8 33·7; 105·1 62·3 31·6; 103·4
DHA (mg/d) 430·7 189·2; 866·1 428·8 179·3; 855·4 358·3 151·7; 726·9 354·5 132·8; 705·5
Total marine n-3 PUFA (mg/d) 692·2 313·7; 1370·1 686·6 295·2; 1355·2 569·2 248·8; 1148·3 563·8 214·8; 1115·8
Fish oil supplements
n 4116 295 5073 295
% 15·9 16·4 17·5 18·8
DPA, docosapentaenoic acid.
* Comparison of baseline characteristics for the cohort as a whole (including both cases and non-cases) and cases with myocardial infarction separately.
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Fatal myocardial infarction
As a secondary analysis, we evaluated the association of fish
consumption and intake of marine n-3 PUFA with fatal MI
(Table 4). After validation, 580 cases (424 men and 156 women)
were categorised as having a fatal MI. Generally, the same
tendency towards a negative association for fatty fish intake was
observed; however, the CI were broader, and the associations
were not statistically significant.
Discussion
In this Danish prospective cohort study conducted in middle-
aged men and women, we examined fish consumption and
dietary intake of marine n-3 PUFA in relation to risk of MI.
Dietary intake of fatty fish was inversely related to incident MI
among men and women when comparing the highest and
lowest quintiles, although the association only remained statis-
tically significant for women after multivariate adjustments. For
women, the same association was shown for total and indivi-
dual marine n-3 PUFA with no material differences between
EPA, DPA and DHA.
Moreover, two studies have been published previously,
based on the Diet Cancer and Health cohort, examining the
association of fish intake with adipose tissue marine n-3 PUFA
content in participants with Acute Coronary Syndrome
(ACS)(6,7). In the present study, the follow-up period was
extended and the number of cases was larger providing
considerably more strength to explore the associations in both
men and women. Thus, Bjerregaard et al.(6) found an inverse
relationship between intake of fatty fish and ACS in men,
suggesting a 32% lower risk from eating a moderate amount of
fatty fish, whereas Joensen et al.(7) demonstrated a lower and
dose-dependent risk of ACS in men with a high content of
marine n-3 PUFA in adipose tissue. Findings in women were
inconsistent and non-significant in both studies(6,7). In the
present, substantially larger, study, we also demonstrated an
inverse relationship in men, but the associations were generally
attenuated during the longer follow-up period, and our results
concerning fatty fish intake suggested a more modest relative
risk of 0·88 when comparing the lowest and the highest quin-
tiles in men. In contrast, our findings in women showed a
consistent pattern compared with the earlier studies and
suggested a 22% lower risk from high fish intake comparing the
highest quintile with the lowest.
There is generally strong supportive evidence from
epidemiological studies(5–12,15) and secondary intervention
trials(17–19) that intake of fish and marine n-3 PUFA is associated
with a lower risk of CHD and sudden cardiac death. Thus, in
2004, He et al. conducted a meta-analysis of prospective cohort
studies, suggesting that one fish serving/week is associated with
a 15% lower risk of fatal CHD and 2–4 servings/week with a
23% lower risk. Today, both the American Heart Association(27)
and the European Society of Cardiology(28) recommend a daily
intake of marine n-3 PUFA of 1 g/d for secondary prevention
of CHD.
Recent clinical trials have questioned the beneficial effects of
n-3 PUFA supplements(20–22), and several reasons have beenTa
b
le
2.
A
ss
oc
ia
tio
n
of
di
et
ar
y
fis
h
in
ta
ke
an
d
m
yo
ca
rd
ia
li
nf
ar
ct
io
n
ac
co
rd
in
g
to
ty
pe
of
fis
h*
(H
az
ar
d
ra
tio
s
(H
R
)
an
d
95
%
co
nf
id
en
ce
in
te
rv
al
s)
M
en
W
om
en
M
od
el
A
1†
M
od
el
A
2‡
M
od
el
B
§
M
od
el
C
||
M
od
el
A
1†
M
od
el
A
2‡
M
od
el
B
§
M
od
el
C
||
H
R
95
%
C
I
H
R
95
%
C
I
H
R
95
%
C
I
H
R
95
%
C
I
H
R
95
%
C
I
H
R
95
%
C
I
H
R
95
%
C
I
H
R
95
%
C
I
In
ta
ke
of
fa
tty
fis
h
In
ta
ke
of
fa
tty
fis
h
Q
1
(0
–
8
g)
1
1
1
1
Q
1
(0
–
6
g)
1
1
1
1
Q
2
(>
8–
13
g)
0·
88
0·
77
,
1·
00
0·
89
0·
79
,
1·
03
0·
90
0·
79
,
1·
03
0·
91
0·
80
,
1·
04
Q
2
(>
6–
10
g)
0·
86
0·
70
,
1·
06
0·
95
0·
77
,
1·
16
0·
95
0·
77
,
1·
16
0·
96
0·
78
,
1·
18
Q
3
(>
13
–
18
g)
0·
84
0·
73
,
0·
96
0·
89
0·
78
,
1·
01
0·
89
0·
78
,
1·
02
0·
90
0·
79
,
1·
03
Q
3
(>
10
–
15
g)
0·
85
0·
69
,
1·
04
0·
96
0·
78
,
1·
17
0·
93
0·
76
,
1·
15
0·
98
0·
80
,
1·
21
Q
4
(>
18
–
28
g)
0·
82
0·
72
,
0·
94
0·
90
0·
79
,
1·
03
0·
90
0·
78
,
1·
03
0·
92
0·
80
,
1·
06
Q
4
(>
15
–
23
g)
0·
90
0·
74
,
1·
10
1·
07
0·
87
,
1·
31
1·
04
0·
85
,
1·
27
1·
11
0·
90
,
1·
36
Q
5
(>
28
g)
0·
83
0·
72
,
0·
94
0·
91
0·
79
,
1·
04
0·
88
0·
77
,
1·
00
0·
93
0·
81
,
1·
07
Q
5
(>
23
g)
0·
69
0·
56
,
0·
85
0·
83
0·
67
,
1·
03
0·
78
0·
63
,
0·
96
0·
86
0·
69
,
1·
08
P
tr
e
n
d
P
<
0·
01
P
=
0·
18
P
=
0·
08
P
=
0·
38
P
tr
e
n
d
P
<
0·
01
P
=
0·
32
P
=
0·
10
P
=
0·
57
In
ta
ke
of
le
an
fis
h
In
ta
ke
of
le
an
fis
h
Q
1
(0
–
14
g)
1
1
1
1
Q
1
(0
–
13
g)
1
1
1
1
Q
2
(>
14
–
21
g)
1·
07
0·
94
,
1·
23
1·
12
0·
98
,
1·
29
1·
13
0·
99
,
1·
29
1·
14
1·
00
,
1·
31
Q
2
(>
13
–
18
g)
0·
94
0·
77
,
1·
16
1·
00
0·
82
,
1·
23
1·
01
0·
82
,
1·
24
1·
03
0·
84
,
1·
27
Q
3
(>
21
–
28
g)
1·
05
0·
92
,
1·
21
1·
11
0·
97
,
1·
27
1·
10
0·
96
,
1·
26
1·
14
0·
99
,
1·
30
Q
3
(>
18
–
24
g)
0·
87
0·
71
,
1·
07
0·
95
0·
77
,
1·
17
0·
93
0·
76
,
1·
15
0·
98
0·
79
,
1·
21
Q
4
(>
28
–
39
g)
1·
01
0·
89
,
1·
16
1·
09
0·
95
,
1·
25
1·
07
0·
94
,
1·
23
1·
12
0·
97
,
1·
29
Q
4
(>
24
–
33
g)
0·
90
0·
73
,
1·
10
0·
99
0·
81
,
1·
22
0·
98
0·
80
,
1·
21
1·
04
0·
84
,
1·
29
Q
5
(>
39
g)
1·
04
0·
91
,
1·
19
1·
07
0·
93
,
1·
23
1·
05
0·
91
,
1·
20
1·
12
0·
97
,
1·
29
Q
5
(>
33
g)
0·
89
0·
72
,
1·
09
0·
95
0·
77
,
1·
16
0·
93
0·
75
,
1·
14
0·
99
0·
79
,
1·
24
P
tr
e
n
d
P
=
0·
91
P
=
0·
51
P
=
0·
78
P
=
0·
21
P
tr
e
n
d
P
=
0·
23
P
=
0·
61
P
=
0·
44
P
=
0·
98
Q
,
qu
in
til
es
.
*
P
va
lu
es
te
st
th
e
hy
po
th
es
is
of
no
tr
en
d
ac
ro
ss
qu
in
til
es
.
†
M
od
el
A
1:
cr
ud
e
an
al
ys
is
.
‡
M
od
el
A
2:
ad
ju
st
ed
fo
r
tr
ad
iti
on
al
ris
k
fa
ct
or
s
in
cl
ud
in
g
sm
ok
in
g,
B
M
I,
w
ai
st
ci
rc
um
fe
re
nc
e,
ph
ys
ic
al
ac
tiv
ity
,
al
co
ho
li
nt
ak
e,
ed
uc
at
io
na
ll
ev
el
an
d
m
en
op
au
sa
ls
ta
tu
s
(w
om
en
).
§
M
od
el
B
:
ad
ju
st
ed
as
m
od
el
A
2
w
ith
ad
di
tio
na
lc
ov
ar
ia
te
s:
hi
st
or
y
of
di
ab
et
es
m
el
lit
us
,
hy
pe
rt
en
si
on
an
d
hy
pe
rc
ho
le
st
er
ol
ae
m
ia
.
||
M
od
el
C
:
ad
ju
st
ed
as
m
od
el
A
2
w
ith
ad
di
tio
na
ld
ie
ta
ry
co
va
ria
te
s:
to
ta
le
ne
rg
y
in
ta
ke
,
in
ta
ke
of
fr
ui
ts
an
d
ve
ge
ta
bl
es
an
d
in
ta
ke
of
nu
ts
.
Fish consumption and myocardial infarction 171
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S000711451600180X
Downloaded from https://www.cambridge.org/core. Aalborg University Library, on 20 Feb 2018 at 14:26:15, subject to the Cambridge Core terms of use, available at
proposed to explain these findings. First of all, methodological
variations, different populations and different interventions
might explain some of the differences. Notably, the recent trials
were all conducted in populations with aggressive background
therapy with antihypertensive, antiplatelet and lipid-lowering
drugs, thereby diminishing the cardio-protective potential of
n-3 PUFA. Furthermore, the effect of n-3 PUFA was mainly seen
for fatal CHD, whereas most recent trials have focused on
non-fatal or composite end points for CHD, and finally the
background dietary fish intake was generally higher in recent
trials in accordance with rising public awareness of a healthy
lifestyle(29). In line with this, a recent meta-analysis reported a
modest effect of marine n-3 PUFA on cardiovascular end
points(3).
Several mechanisms have been suggested to explain the
cardio-protective properties attributed to marine n-3 PUFA(2,4,30).
These mechanisms may explain possible antithrombotic(19,31,32)
and/or antiarrhythmic(18,33,34) effects of marine n-3 PUFA that
may reduce the risk of CHD. In addition, anti-inflammatory
properties have been reported, possibly inferring a stabilising
effect of marine n-3 PUFA on human atherosclerotic plaques(35,36)
that may decrease the risk of plaque rupture, and thus MI and
CHD. Finally, marine n-3 PUFA also lower plasma TAG(37),
increase serum adiponectin(38,39) and may slightly reduce blood
pressure(2). The mechanisms by which n-3 PUFA interact with the
risk of MI in the present study are uncertain, but the analyses
suggest that the content of marine n-3 PUFA is important, as the
inverse relationship between fish intake and MI was observed for
fatty fish and not lean fish. Furthermore, intake of fatty fish was
highly correlated with intake of total and individual n-3 PUFA
(EPA and DHA in particular). A few studies have examined the
effect of individual marine n-3 PUFA, as most trials have
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Fig. 2. Spline curves showing hazard ratios and 95% CI ( ) for the associations between (a) fatty fish, (b) lean fish, (c) total marine n-3 PUFA and incident myocardial
infarction. Data presented for model B, adjusting for traditional risk factors and medical history, with the median dietary intake as reference. , Intake by quintiles.
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Table 3. Association of myocardial infarction and calculated intakes of individual and total marine n-3 PUFA*
(Hazard ratios (HR) and 95% confidence intervals)
Men Women
Model A1† Model A2‡ Model B§ Model C|| Model A1† Model A2‡ Model B§ Model C||
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
EPA EPA
Q1 (0–99mg) 1 1 1 1 Q1 (0–82mg) 1 1 1 1
Q2 (>99–151mg) 0·88 0·77, 1·01 0·90 0·79, 1·03 0·89 0·78, 1·02 0·90 0·79, 1·03 Q2 (>82–125mg) 0·93 0·76, 1·14 1·00 0·81, 1·22 0·98 0·80, 1·21 1·01 0·82, 1·24
Q3 (>151–207mg) 0·93 0·82, 1·06 0·98 0·86, 1·12 0·97 0·85, 1·11 0·97 0·85, 1·12 Q3 (>125–173mg) 0·74 0·60, 0·92 0·82 0·66, 1·02 0·80 0·65, 1·00 0·84 0·67, 1·05
Q4 (>207–294mg) 0·92 0·81, 1·05 0·99 0·87, 1·13 0·97 0·85, 1·11 0·98 0·86, 1·13 Q4 (>173–247mg) 1·00 0·82, 1·22 1·14 0·93, 1·39 1·11 0·91, 1·35 1·18 0·96, 1·46
Q5 (>294mg) 0·89 0·78, 1·01 0·93 0·81, 1·07 0·90 0·79, 1·03 0·92 0·80, 1·07 Q5 (>247mg) 0·75 0·61, 0·92 0·83 0·67, 1·03 0·79 0·64, 0·97 0·87 0·69, 1·10
Ptrend P= 0·20 P=0·76 P=0·42 P=0·69 Ptrend P=0·04 P= 0·36 P=0·14 P=0·73
DPA DPA
Q1 (0–58mg) 1 1 1 1 Q1 (0–42mg) 1 1 1 1
Q2 (>58–74mg) 0·87 0·76, 1·00 0·88 0·77, 1·01 0·88 0·77, 1·01 0·87 0·75, 1·00 Q2 (>42–56mg) 0·79 0·64, 0·97 0·83 0·68, 1·02 0·83 0·67, 1·02 0·84 0·68, 1·04
Q3 (>74–91mg) 0·98 0·86, 1·12 0·98 0·86, 1·12 0·99 0·87, 1·13 0·97 0·84, 1·12 Q3 (>56–69mg) 0·77 0·63, 0·94 0·84 0·68, 1·03 0·83 0·67, 1·02 0·86 0·69, 1·07
Q4 (>91–113mg) 0·98 0·86, 1·12 0·98 0·85, 1·12 0·98 0·85, 1·11 0·96 0·82, 1·11 Q4 (>69–88mg) 0·87 0·71, 1·06 0·92 0·76, 1·13 0·91 0·74, 1·11 0·95 0·76, 1·20
Q5 (>113mg) 0·97 0·85, 1·11 0·94 0·82, 1·07 0·94 0·82, 1·07 0·92 0·78, 1·08 Q5 (>88mg) 0·80 0·65, 0·98 0·82 0·67, 1·00 0·81 0·66, 0·99 0·84 0·66, 1·08
Ptrend P= 0·78 P=0·84 P=0·61 P=0·74 Ptrend P=0·11 P= 0·19 P=0·13 P=0·46
DHA DHA
Q1 (0–257mg) 1 1 1 1 Q1 (0–211mg) 1 1 1 1
Q2 (>257–373mg) 0·91 0·80, 1·05 0·93 0·81, 1·06 0·93 0·81, 1·06 0·92 0·80, 1·05 Q2 (>211–307mg) 0·81 0·66, 0·99 0·86 0·70, 1·06 0·87 0·71, 1·07 0·87 0·71, 1·08
Q3 (>373–496mg) 0·92 0·80, 1·05 0·95 0·83, 1·08 0·95 0·83, 1·09 0·94 0·82, 1·07 Q3 (>307–413mg) 0·79 0·64, 0·96 0·87 0·70, 1·07 0·86 0·70, 1·05 0·89 0·72, 1·10
Q4 (>496–683mg) 0·96 0·84, 1·10 1·01 0·88, 1·15 1·00 0·87, 1·14 0·99 0·86, 1·14 Q4 (>413–573mg) 0·88 0·72, 1·07 0·97 0·79, 1·18 0·95 0·78, 1·16 0·99 0·80, 1·23
Q5 (>683mg) 0·90 0·79, 1·03 0·92 0·80, 1·05 0·90 0·78, 1·03 0·90 0·77, 1·05 Q5 (>573mg) 0·75 0·61, 0·93 0·82 0·66, 1·01 0·79 0·64, 0·97 0·85 0·67, 1·07
Ptrend P= 0·29 P=0·56 P=0·34 P=0·44 Ptrend P=0·04 P= 0·22 P=0·09 P=0·49
Total marine n-3 PUFA Total marine n-3 PUFA
Q1 (0–421mg) 1 1 1 1 Q1 (0–341mg) 1 1 1 1
Q2 (>421–602mg) 0·94 0·82, 1·07 0·95 0·83, 1·09 0·95 0·83, 1·08 0·94 0·82, 1·08 Q2 (>341–491mg) 0·84 0·68, 1·03 0·90 0·74, 1·11 0·91 0·74, 1·11 0·92 0·75, 1·13
Q3 (>602–793mg) 0·92 0·80, 1·05 0·95 0·83, 1·09 0·96 0·84, 1·09 0·94 0·82, 1·08 Q3 (>491–656mg) 0·78 0·63, 0·96 0·86 0·70, 1·06 0·85 0·69, 1·04 0·88 0·71, 1·10
Q4 (>793–1083mg) 0·95 0·83, 1·09 1·00 0·87, 1·14 0·99 0·86, 1·13 0·98 0·85, 1·13 Q4 (>656–904mg) 0·88 0·72, 1·07 0·97 0·80, 1·19 0·95 0·78, 1·17 1·01 0·81, 1·25
Q5 (>1083mg) 0·92 0·80, 1·05 0·94 0·82, 1·07 0·91 0·80, 1·04 0·92 0·79, 1·07 Q5 (>904mg) 0·77 0·63, 0·95 0·84 0·69, 1·04 0·81 0·66, 0·99 0·88 0·69, 1·11
Ptrend P= 0·29 P=0·60 P=0·36 P=0·49 Ptrend P=0·04 P= 0·25 P=0·11 P=0·56
Q, quintiles; DPA, docosapentaenoic acid.
* P values test the hypothesis of no trend across quintiles.
† Model A1: crude analysis.
‡ Model A2: adjusted for traditional risk factors including smoking, BMI, waist circumference, physical activity, alcohol intake, educational level and menopausal status (women).
§ Model B: adjusted as model A2 with additional covariates: history of diabetes mellitus, hypertension and hypercholesterolaemia.
|| Model C: adjusted as model A2 with additional dietary covariates: total energy intake, total intake of SFA, MUFA and PUFA (excl. marine n-3 PUFA) and dietary fibre.
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Table 4. Association of dietary fish consumption and intake of marine n-3 PUFA with fatal myocardial infarction*
(Hazard ratios (HR) and 95% confidence intervals)
Men Women
Model A1† Model A2‡ Model B§ Model C|| Model A1† Model A2‡ Model B§ Model C||
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Intake of fatty fish Intake of fatty fish
Q1 (0–8 g) 1 1 1 1 Q1 (0–6 g) 1 1 1 1
Q2 (>8–13 g) 0·75 0·56, 1·01 0·77 0·57, 1·04 0·76 0·57, 1·03 0·79 0·59, 1·07 Q2 (>6–10 g) 1·04 0·66, 1·63 1·15 0·73, 1·82 1·15 0·73, 1·81 1·18 0·75, 1·87
Q3 (>13–18 g) 0·74 0·55, 1·00 0·80 0·59, 1·06 0·80 0·60, 1·08 0·82 0·60, 1·10 Q3 (>10–15 g) 0·92 0·58, 1·46 1·06 0·67, 1·70 1·04 0·65, 1·65 1·10 0·69, 1·78
Q4 (>18–28 g) 0·76 0·57, 1·02 0·85 0·63, 1·14 0·85 0·63, 1·14 0·88 0·65, 1·19 Q4 (>15–23 g) 0·49 0·28, 0·85 0·60 0·34, 1·05 0·58 0·33, 1·02 0·62 0·35, 1·09
Q5 (>28g) 0·78 0·58, 1·04 0·86 0·64, 1·15 0·81 0·61, 1·09 0·89 0·65, 1·21 Q5 (>23g) 0·75 0·47, 1·21 0·94 0·58, 1·52 0·87 0·53, 1·40 0·94 0·56, 1·56
Ptrend P=0·13 P= 0·50 P=0·33 P= 0·66 Ptrend P=0·03 P= 0·22 P=0·12 P= 0·25
Intake of lean fish Intake of lean fish
Q1 (0–8 g) 1 1 1 1 Q1 (0–6 g) 1 1 1 1
Q2 (>8–13 g) 0·90 0·65, 1·24 0·95 0·69, 1·31 0·97 0·70, 1·34 0·99 0·72, 1·37 Q2 (>6–10 g) 0·78 0·47, 1·31 0·85 0·51, 1·42 0·86 0·51, 1·44 0·89 0·53, 1·50
Q3 (>13–18 g) 1·11 0·82, 1·50 1·17 0·87, 1·59 1·16 0·86, 1·58 1·26 0·92, 1·71 Q3 (>10–15 g) 1·07 0·67, 1·71 1·18 0·74, 1·89 1·17 0·73, 1·88 1·25 0·77, 2·03
Q4 (>18–28 g) 1·09 0·80, 1·48 1·18 0·87, 1·60 1·17 0·86, 1·58 1·27 0·93, 1·74 Q4 (>15–23 g) 0·91 0·56, 1·48 1·04 0·64, 1·70 1·03 0·63, 1·68 1·12 0·67, 1·86
Q5 (>28g) 1·19 0·88, 1·60 1·23 0·91, 1·66 1·18 0·88, 1·60 1·34 0·97, 1·84 Q5 (>23g) 0·95 0·59, 1·54 1·05 0·65, 1·70 1·03 0·64, 1·68 1·12 0·66, 1·90
Ptrend P=0·12 P= 0·07 P=0·14 P= 0·03 Ptrend P=0·95 P= 0·62 P=0·70 P= 0·46
Total marine n-3 PUFA intake Total marine n-3 PUFA intake
Q1 (0–421mg) 1 1 1 1 Q1 (0–341mg) 1 1 1 1
Q2 (>421–602mg) 0·76 0·55, 1·04 0·77 0·56, 1·05 0·75 0·55, 1·03 0·76 0·56, 1·05 Q2 (>341–491mg) 1·09 0·69, 1·72 1·20 0·76, 1·90 1·19 0·75, 1·89 1·25 0·78, 2·00
Q3 (>602–793mg) 0·96 0·72, 0·29 1·00 0·74, 1·34 1·01 0·75, 1·35 1·00 0·73, 1·35 Q3 (>491–656mg) 0·82 0·50, 1·33 0·92 0·56, 1·50 0·90 0·55, 1·47 0·94 0·56, 1·57
Q4 (>793–1083mg) 0·93 0·69, 1·25 0·98 0·73, 1·32 0·96 0·72, 1·30 0·99 0·72, 1·35 Q4 (>656–904mg) 0·75 0·45, 1·23 0·86 0·52, 1·43 0·84 0·51, 1·39 0·90 0·52, 1·54
Q5 (>1083mg) 0·94 0·70, 1·26 0·95 0·71, 1·28 0·90 0·67, 1·21 0·99 0·71, 1·37 Q5 (>904mg) 0·75 0·46, 1·23 0·85 0·52, 1·39 0·81 0·49, 1·33 0·79 0·44, 1·41
Ptrend P=0·86 P= 0·72 P=0·97 P= 0·58 Ptrend P=0·09 P= 0·24 P=0·17 P= 0·22
Q, quintiles.
* P values test the hypothesis of no trend across quintiles.
† Model A1: crude analysis.
‡ Model A2: adjusted for smoking, BMI, waist circumference, physical activity, alcohol intake, educational level and menopausal status (women).
§ Model B: adjusted as model A2 with additional covariates: history of diabetes mellitus, hypercholesterolaemia and hypertension.
|| Model C: Adjusted as model A2 with additional covariates. For dietary intake of fish, we adjusted for dietary covariates: total energy intake, intake of fruits and vegetables and intake of nuts. For intake of total n-3 PUFA, we adjusted for
specific nutrients: total intake/content of SFA, MUFA and PUFA (excl. marine n-3 PUFA) and dietary fibre. Total marine n-3 PUFA was adjusted for total energy intake.
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examined an intervention consisting of a combination of EPA and
DHA, as these are the major marine n-3 PUFA found in seafood
and fish oil. However, a large intervention trial in a Japanese
population used a supplement of purified EPA and produced a
significant reduction in major cardiovascular events, suggesting
anti-atherosclerotic effects of EPA independently of other marine
n-3 PUFA(19). Accordingly, important differential effects have
been suggested between the major n-3 PUFA, but more studies
on individual n-3 PUFA are warranted(40). In the present study,
we showed that EPA, DPA and DHA were similarly related to MI,
but the study design did not allow for further investigation into the
mechanistic aspects of individual n-3 PUFA.
Strengths and limitations
This study was based on a large prospective cohort study and
holds the advantages of the prospective design.
The dietary intake of fish and marine n-3 PUFA was
evaluated in a detailed manner. First, we assessed fish intake
using detailed semi-quantitative FFQ including twenty-six
questions concerning fish intake. This allowed us to
differentiate by types of fish, thereby grouping fish consump-
tion into fatty and lean fish depending on the content of marine
n-3 PUFA. Second, we calculated the intake of major marine n-3
PUFA (EPA, DPA and DHA), to assess these fatty acids
individually.
There was a limited loss to follow-up, and the assessment of
outcome data was thorough and complete. All outcome data
from the National Patient Registry or Causes of Death Registry
were either examined from medical records or from a complete
list of diagnoses and medical procedure codes, ensuring high
validity of cases.
Adjustment for potential confounding was applied in different
steps allowing for a more detailed interpretation of the results. In
model A2, we adjusted for traditional risk factors for MI, which
has a clear and straightforward interpretation. In model B, we
applied a second layer of variables adjusting for medical history.
These variables are normally considered traditional risk factors for
MI and potential confounders, but at the same time may represent
intermediate steps in causal pathways by which n-3 PUFA affect
the risk of MI. In our opinion, model B represents the most
complete analysis including important covariates, and the risk of
introducing bias by including intermediate variables is out-
weighed by the risk of residual confounding by not including
these variables. This is, however, open for discussion. Finally, we
included dietary variables in addition to the traditional risk factors
from model A2 (model C). This model implies adjustment for
potential confounding from other aspects of the diet, but it may
also introduce dietary patterns that are less comparable with the
ordinary dietary pattern. Generally, the differences in measures of
association between models were moderate or small, suggesting
that confounding was not a major concern in this study.
This study also has certain limitations. Although age was evenly
distributed among men and women, there was a markedly higher
proportion of male cases and there were relatively few female
cases, which made the CI wider for measures of association when
analysing data in women, particularly fatal cases. The median
follow-up period was 17·0 years, and dietary measures were not
assessed during the study period. A long follow-up period
allowed us to accumulate more outcome events, but the partici-
pants might have changed their diet over time. Furthermore,
changes in standard medical care and general changes in lifestyle
and public awareness of disease prevention might have
influenced the participants’ risk profile. To address this issue, we
performed supplementary analysis by stratifying date of birth and
testing for interaction from date of birth. No significant interaction
was detected, and stratification did not affect the measures of
association. Another concern when using FFQ is the chance of
measurement error and various sources of bias, and evaluating
biomarkers of marine n-3 PUFA intake would add strength to the
dietary data. In this article we do not present data on biomarkers
of n-3 PUFA, but our group recently published an article
investigating the association between adipose tissue content of
marine n-3 PUFA and MI, supporting the findings of this dietary
study(41).
Conclusions
In this prospective cohort study, we found a high intake of fatty
fish to be inversely related to incident MI in both men and
women when comparing the highest and lowest quintiles.
However, a clear dose–response relationship could not be
established, and the test for trends across quintiles was not
statistically significant in the adjusted analyses. Lean fish was
not associated with MI. This study supports the current view
that consumption of fatty fish may protect against MI.
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